Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Large-scale serum-free culture method for rhIL-12 engineering cells

A serum-free, large-scale technology for cell culture and culture

Active Publication Date: 2014-04-02
UNIV OF SCI & TECH OF CHINA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Before the present invention, some researchers respectively inserted the genes of p40 and p35 into the same vector for co-transfection (Dai Yan, Chen Weifeng. Expression of human recombinant interleukin 12 in CHO cells. Biochemistry and Biophysics Progress, 1998, 25(3): 254-258), or the gene fusion of p40 and p35 to construct IL-12 single-chain eukaryotic expression vector for expression (Zhang Mei, Si Lusheng, Jin Li et al. Recombinant human single-chain Construction of interleukin-12 fusion gene, eukaryotic expression and biological activity determination. Chinese Journal of Hematology, 2000, 21(12): 636-640), or conventional culture of vector cells transfected with hIL-12 (Liu Meng, Zheng Shanshan. Recombinant human interleukin 12 gene in CHO-dhfr - Stable expression of cells. Journal of Immunology, 1996, 12(4): 215-219), but failed to achieve high expression of rhIL-12 in large-scale serum-free culture of carrier cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Large-scale serum-free culture method for rhIL-12 engineering cells
  • Large-scale serum-free culture method for rhIL-12 engineering cells
  • Large-scale serum-free culture method for rhIL-12 engineering cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0046] Example: Screening of rhIL-12 engineered cells grown in serum-free suspension state, pressurized medium suitable for growth of rhIL-12 engineered cells, selection of serum-free medium for production, and large-scale cultivation of stable rhIL-12 engineered cells Craft establishment

[0047] 1. Materials

[0048] For rhIL-12 engineered cells (obtained according to the description of Chinese Patent Publication No. CN1467292A), the original medium is DMEM medium containing 10% newborn bovine serum. DMEM liquid medium, CHO ⅢA liquid medium, CD CHO A liquid medium, CD CHO liquid medium and SFM liquid medium were purchased from Invitrogen Company; HyQ SFX-CHO serum-free medium was purchased from Hyclone Company. 100×non-essential amino acids, 100×sodium pyruvate and 100×HT were purchased from Invitrogen; adenosine, guanosine, cytidine, uridine and thymidine were purchased from BioBASic; L -Glutamine, L-asparagine and L-proline were purchased from Sigma; newborn bovine serum...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a large-scale serum-free culture method for rhIL-12 engineering cells, which comprises the following step of: inoculating rhIL-12 engineering cells in a logarithmic phase into a serum-free and protein-free medium for culture, wherein the medium is a CD CHO liquid medium comprising sodium pyruvate at the final concentration of 0.8 to 1.2mM, hypoxanthine at the final concentration of 0.075 to 0.125mM, thymidine at the final concentration of 0.012 to 0.020mM, adenosine at the final concentration of 0.5 to 0.9mg / L, guanosine at the final concentration of 0.5 to 0.9mg / L, cytidine at the final concentration of 0.5 to 0.9mg / L, uridine at the final concentration of 0.5 to 0.9mg / L, L-glutamine at the final concentration of 0.4 to 0.8mg / L, L-asparagine at the final concentration of 0.4 to 0.8mg / L, L-proline at the final concentration of 1.5 to 2.0mg / L and non-essential amino acid at the final concentration of 0.08 to 0.125mM. The invention also provides a medium used in the method. By the medium and the culture method, a high-yield and high-activity recombinant human interleukin-12 can be obtained.

Description

technical field [0001] The invention belongs to the field of biological technology, and relates to a cell culture medium and a culture method. Specifically, the present invention is a method for large-scale cultivation of recombinant human interleukin-12 engineered cells using a serum-free and protein-free medium. By using this method to cultivate recombinant human interleukin-12 engineered cells, high Yield, high activity of recombinant human interleukin-12. Background technique [0002] Human Interleukin-12 (Human Interleukin 12, hIL-12) is a heterodimeric cytokine composed of two subunits p35 and p40 linked by multiple pairs of disulfide bonds. hIL-12, also known as NK cell stimulating factor (NKSF), has strong anti-tumor and anti-viral effects. This effect is mediated by the body's natural killer cells (Natural killer cells, NK cells). hIL-12 also It plays an important role in the development, differentiation, maturation and activation of cytotoxic T cells, helper T ce...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10
Inventor 田志刚程民魏海明郑晓东孙汭费保珍
Owner UNIV OF SCI & TECH OF CHINA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products